<unk>  (INN) is a calcium channel blocker.  
Clinidipine  is the novel calcium antagonist accompanied with L-type and N-type calcium channel blocking function. It was jointly developed by Fuji Viscera Pharmaceutical Company, Japan and Ajinomoto, Japan and approved to come into market for the first time and used for high blood pressure treatment in 1995. Compared with other calcium antagonists, clinidipine   can act on the N-type calcium-channel that existing sympathetic nerve end besides acting on L-type calcium-channel that similar to most of the calcium antagonists.
Cilnidipine
Barnidipine
Clevidipine
Lacidipine
Manidipine
Benidipine
Lercanidipine
Bamipine